Epistem, the UK biotechnology and personalized medicine company with expertise in skin biology and delivery of dermatological testing services, and ScandiDerma, a Norwegian company with expertise in developing new dermatological ingredients from biomass, today announced that they aim to develop a new in vitro human living skin equivalent model for testing inflammatory responses. This is…
Life Sciences & Biomedical News
Epistem Plc. (LSE: EHP), the UK biotechnology and personalised medicine company, today announced it will be presenting advances in two independent research platforms at the American Association for Cancer Research Annual Meeting in Washington DC on Tuesday 9th April. Dr Gino Mele, Operations Director of Epistem’s Biomarker Division, will present data from Epistem’s plucked hair…
Epistem plc, the UK biotechnology and personalized medicine company, has announced that their Contract Research Division’s histology and immunohistochemistry (IHC) laboratories have been awarded Good Clinical Laboratory Practise (GCLP) accreditation status. The Contract Research Division provides solutions to support preclinical testing and clinical drug development programs within pharmaceutical and biotechnology organizations, providing valuable information on…
Bionow is delighted to announce the winners of the 2012 Bionow Annual Awards. The winners were presented at the Bionow Annual Awards Dinner which took place on 29th November 2012 at The Mere Golf Resort and Spa. The awards dinner was attended by over 280 executives from the biomedical industry and is the highlight of…
MIDAS, Manchester’s inward investment agency, has exceeded targets supporting the creation of over 3,000 jobs across Greater Manchester in 2011-12. The investment agency’s end-of-year figures, released today, show that across 70 successful projects, MIDAS created 3,114 jobs and also assisted in the safeguarding of 460 jobs – bringing the total number of jobs supported…